Omari

Omarigliptin INN

DIABETES

INDICATION

Omari is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

DOSAGE AND ADMINISTRATION

The usual recommended dose of Omarigliptin is 25mg once weekly as monotherapy or as add-on therapy for optimization of glycemic control. The dosage should be reduced to 12.5mg once weekly in patients with severe renal dysfunction and in patients with end-stage renal failure or in those requiring hemodialysis or peritoneal dialysis according to the following table:

Renal dysfunction	eGFR (ml/min/1.73m2) Serum creatinine values(mg/dL) *eGFR<30	Dose
Severe end-stage kidney failure	Men: Cr>:1.9 Women: Cr>1.4	12.5mg once a week

rnrn

*: Conversion value corresponding to the eGFR (60 years of age)
Missed dose: If missed a dose, it is advised to take the missed dose as soon as possible and then follow regular weekly dosing schedule. Patients should never take two doses at one time.

COMPOSITION

Omari 25 Tablet: Each Box contains 1×4 Tablets in Alu-Alu blister.
Omari 12.5 Tablet: Each Box contains 1×4 Tablets in Alu-Alu blister.